semaglutide tirzepatide combination Novo weight-loss drug may preserve lean body mass better than Lilly's, study finds Semaglutide vs. Tirzepatide: Which GLP-1

Body Weight and Health Factors A persons baseline health profile, including body weight and metabolic status, may be considered when planning a dosing approach

13 GLP-1 RA cardiovascular outcome trials 29 and head-to-head studies, 1529 with a follow-up range of 0.55.4 years, have documented that GLP-1 RAs increase heart rate by 0.15.7 b.p.m., with an average increase of 2.4 b.p.m

The cardiometabolic case for GLP-1 receptor agonists in established disease is now strong on the evidence side, not the marketing side

Slower digestion, occasional mild nausea, a feeling of food sitting in the stomach longer than usual

doi: 10.1002/biof.1406 [DOI] [PubMed] [Google Scholar] 122

This is a scientific way of saying it keeps food in your stomach for a longer period